Health
Engineered stem cells reverse new-onset type 1 diabetes in mice
A group of researchers at the Medical University of South Carolina (MUSC) has recently developed a new stem cell therapy with a remarkable ability to reverse new-onset type 1 diabetes (T1D) in a mouse model of the disease.
Summary
A group of researchers at the Medical University of South Carolina (MUSC) has recently developed a new stem cell therapy with a remarkable ability to reverse new-onset type 1 diabetes (T1D) in a mouse model of the disease. The work is published in the journal Molecular Therapy . Hongjun Wang, Ph.D., associate director of the South Carolina Clinical & Translational Research (SCTR) Institute Pilot Program and co-scientific director for the Center for Cellular Therapy, led the team.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
- Supervised physical therapy improves short-term knee pain and function after ACL surgery in young adultsContinue reading
- Bedside blood test can deliver results in under 10 minutes to guide urgent stroke careContinue reading
- Metabolic activity of gut bacteria can either promote or inhibit function of CAR T cells in cancer therapyContinue reading
- A missing piece in the cell death and inflammation signaling pathway puzzle has been revealedContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow